Literature DB >> 12571149

Selected contribution: Peripheral chemoreflex function in high-altitude natives and patients with chronic mountain sickness.

Fabiola Léon-Velarde1, Alfredo Gamboa, Maria Rivera-Ch, Jose-Antonio Palacios, Peter A Robbins.   

Abstract

Peripheral chemoreflex function was studied in high-altitude (HA) natives at HA, in patients with chronic mountain sickness (CMS) at HA, and in sea-level (SL) natives at SL. Results were as follows. 1) Acute ventilatory responses to hypoxia (AHVR) in the HA and CMS groups were approximately one-third of those of the SL group. 2) In CMS patients, some indexes of AHVR were modestly, but significantly, lower than in healthy HA natives. 3) Prior oxygenation increased AHVR in all subject groups. 4) Neither low-dose dopamine nor somatostatin suppressed any component of ventilation that could not be suppressed by acute hyperoxia. 5) In all subject groups, the ventilatory response to hyperoxia was biphasic. Initially, ventilation fell but subsequently rose so that, by 20 min, ventilation was higher in hyperoxia than hypoxia for both HA and CMS subjects. 6) Peripheral chemoreflex stimulation of ventilation was modestly greater in HA and CMS subjects at an end-tidal Po(2) = 52.5 Torr than in SL natives at an end-tidal Po(2) = 100 Torr. 7) For the HA and CMS subjects combined, there was a strong correlation between end-tidal Pco(2) and hematocrit, which persisted after controlling for AHVR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12571149     DOI: 10.1152/japplphysiol.00858.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Measuring the ventilatory response to hypoxia.

Authors:  James Duffin
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

2.  Lung disease at high altitude.

Authors:  Joshua O Stream; Andrew M Luks; Colin K Grissom
Journal:  Expert Rev Respir Med       Date:  2009-12       Impact factor: 3.772

3.  Cold pressor response in high landers versus low landers.

Authors:  Jagdish Narayan; Archana Ghildiyal; Manish Goyal; Dileep Verma; Shraddha Singh; Sunita Tiwari
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 4.  High-Altitude Erythrocytosis: Mechanisms of Adaptive and Maladaptive Responses.

Authors:  Francisco C Villafuerte; Tatum S Simonson; Daniela Bermudez; Fabiola León-Velarde
Journal:  Physiology (Bethesda)       Date:  2022-01-10

Review 5.  Immediate and long-term responses of the carotid body to high altitude.

Authors:  David F Wilson; Arijit Roy; Sukhamay Lahiri
Journal:  High Alt Med Biol       Date:  2005       Impact factor: 1.981

Review 6.  The autonomic nervous system at high altitude.

Authors:  Roger Hainsworth; Mark J Drinkhill; Maria Rivera-Chira
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

7.  Relationships Between Chemoreflex Responses, Sleep Quality, and Hematocrit in Andean Men and Women.

Authors:  Erica C Heinrich; Jeremy E Orr; Dillon Gilbertson; Cecilia Anza-Ramirez; Pamela N DeYoung; Matea A Djokic; Noemi Corante; Gustavo Vizcardo-Galindo; Jose L Macarlupu; Eduardo Gaio; Frank L Powell; Atul Malhotra; Francisco C Villafuerte; Tatum S Simonson
Journal:  Front Physiol       Date:  2020-05-06       Impact factor: 4.566

Review 8.  Time Domains of Hypoxia Responses and -Omics Insights.

Authors:  James J Yu; Amy L Non; Erica C Heinrich; Wanjun Gu; Joe Alcock; Esteban A Moya; Elijah S Lawrence; Michael S Tift; Katie A O'Brien; Jay F Storz; Anthony V Signore; Jane I Khudyakov; William K Milsom; Sean M Wilson; Cynthia M Beall; Francisco C Villafuerte; Tsering Stobdan; Colleen G Julian; Lorna G Moore; Mark M Fuster; Jennifer A Stokes; Richard Milner; John B West; Jiao Zhang; John Y Shyy; Ainash Childebayeva; José Pablo Vázquez-Medina; Luu V Pham; Omar A Mesarwi; James E Hall; Zachary A Cheviron; Jeremy Sieker; Arlin B Blood; Jason X Yuan; Graham R Scott; Brinda K Rana; Paul J Ponganis; Atul Malhotra; Frank L Powell; Tatum S Simonson
Journal:  Front Physiol       Date:  2022-08-08       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.